🚀💸 Limited time offer: $49 for pro access to 1,000+ investors
Tatiana Solis
AbCellera
Description
AbCellera Biologics is a biotechnology company that develops antibody therapeutics to improve patient outcomes.
Email Address
Website
Investment stages
Series D
Series B
Series C